Investigative and clinical urology · 2026
Upregulation of aquaporin-2 and caveolins in rat bladder with outlet obstruction-induced detrusor overactivity.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Seong Hyeon, Chung Ho Seok, Lim Do Gyeong, Kim Sun-Ouck
Аннотация
PURPOSE: Bladder outlet obstruction (BOO) leads to detrusor overactivity (DO) and structural remodeling of the bladder. However, the molecular mechanisms underlying this process remain incompletely understood.
MATERIALS AND METHODS: In a rat model of partial BOO, we assessed bladder function via cystometry and evaluated histological changes using hematoxylin and eosin staining. The expression and localization of aquaporin (AQP)-2 and caveolin (CAV)-1, -2, and -3 were analyzed by Western blotting and immunofluorescence in bladder tissues. Additionally, immunostaining was performed in cultured human bladder smooth muscle cells to assess protein co-localization.
RESULTS: BOO rats exhibited elevated detrusor contraction pressure and shortened intercontraction intervals. Histologically, hypertrophied smooth muscle bundles and increased extracellular matrix were observed. Western blot analysis revealed significant upregulation of AQP2 and CAV1-3 in BOO bladders. Tissue immunofluorescence demonstrated increased expression and redistribution of these proteins in the detrusor muscle. Cultured cell analysis confirmed subcellular co-localization of AQP2 with CAV1-3.
CONCLUSIONS: DO induced by BOO is associated with upregulated expression of AQP2 and CAV1-3 in the urinary bladder. The coexpression observed in bladder cells suggests potential molecular interactions between AQP2 and CAVs that may contribute to the pathophysiology of BOO-related bladder dysfunction.
MATERIALS AND METHODS: In a rat model of partial BOO, we assessed bladder function via cystometry and evaluated histological changes using hematoxylin and eosin staining. The expression and localization of aquaporin (AQP)-2 and caveolin (CAV)-1, -2, and -3 were analyzed by Western blotting and immunofluorescence in bladder tissues. Additionally, immunostaining was performed in cultured human bladder smooth muscle cells to assess protein co-localization.
RESULTS: BOO rats exhibited elevated detrusor contraction pressure and shortened intercontraction intervals. Histologically, hypertrophied smooth muscle bundles and increased extracellular matrix were observed. Western blot analysis revealed significant upregulation of AQP2 and CAV1-3 in BOO bladders. Tissue immunofluorescence demonstrated increased expression and redistribution of these proteins in the detrusor muscle. Cultured cell analysis confirmed subcellular co-localization of AQP2 with CAV1-3.
CONCLUSIONS: DO induced by BOO is associated with upregulated expression of AQP2 and CAV1-3 in the urinary bladder. The coexpression observed in bladder cells suggests potential molecular interactions between AQP2 and CAVs that may contribute to the pathophysiology of BOO-related bladder dysfunction.